GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on American soil in pursuit of appeasing President Donald Trump as he threatens ...

Scientists have discovered a new way to advance drug discovery and diagnostics by targeting a part of the proteome (the ...

Researchers found that Halicin, an AI-identified drug, effectively inhibited most multidrug-resistant bacteria except ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

It wasn't clear late Wednesday if Ambassador Rosa Delmy Cañas had left Mexico yet. On Tuesday, García Harfuch was summarizing drug seizures during the president’s daily news briefing when he ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

The first drug to treat infants sick with malaria is approved by Swiss authority Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small ...

Ovidio Guzman Lopez, the son of notorious Mexican drug kingpin "El Chapo," intends to plead guilty to drug trafficking charges in the U.S., according to court documents.